Aurobindo Pharma's net profit FY 2013-2023

Published by A. Minhas, Aug 28, 2023
In fiscal year 2023, Aurobindo Pharma Limited's net profit was around nearly 19.28 billion Indian rupees. That year, 85 percent of the formulations contributed to the revenue, while APIs made up 15 percent.

Net profit of Aurobindo Pharma Limited from financial year 2013 to 2023 (in billion Indian rupees)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

August 2023

Region

India

Survey time period

FY 2013 to FY 2023

Supplementary notes

*Includes higher sales from limited competition product.

**Includes exceptional gain of 23.4 billion (net of tax) on sale of Natrol.

India's financial year begins in April and ends in March. For example, FY 2020 started in April 2019 and ended in March 2020.

One Indian rupee is equal to 0.011 euros and 0.012 dollars as of August 2023.

Values have been rounded for clarity.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " GlaxoSmithKline Pharmaceuticals Limited India "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you GlaxoSmithKline Pharmaceuticals Limited India

Market overview

6

GSK India - key figures

6

Product portfolio

3

Main competitiors

4

Further related statistics

19

Further Content: You might find this interesting as well

Statistics

Topics

GlaxoSmithKline Pharmaceuticals Limited IndiaGlobal pharmaceutical industrySanofiPfizerJohnson & Johnson
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu